Production of antibiotics via Genetic engineering applications / A Review Article
Main Article Content
Abstract
Genetic engineering techniques are evolving, increasing the prospect of altering microorganisms to generate antibiotics more effectively. This article will showcase some of the successful implementations of these strategies, with a focus on the quantitative and qualitative gains in antibiotic production. It also discusses the obstacles facing this field and how to overcome them in order to create sustainable and effective antibiotic production, which has resulted in significant changes in many sectors of the modern economy, particularly agriculture and its dependent businesses. Industrial fermentation, the employment of free and bound enzymes and attracted
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
- Cobb, R. E., Si, T., & Zhao, H. (2021). Directed evolution: Past, present, and future. AIChE Journal,
(10), e17360. https://doi.org/10.1002/aic.17360
-Duan, F., & March, J. C. (2020). Engineered bacteriophage with CRISPR-Cas9 targeting new
antibiotic-resistant bacteria. ACS Synthetic Biology, 9(2), 321-331.
https://doi.org/10.1021/acssynbio.9b00453
-Liu, Y., Ma, C., & Zhao, H. (2022). Synthetic biology approaches for novel antibiotic production by
engineered microorganisms. Biotechnology Advances, 54, 107792.
https://doi.org/10.1016/j.biotechadv.2021.107792
-Martín, J. F., & Liras, P. (2020). Engineering metabolic pathways to develop new antibiotics.
Microbial Biotechnology, 13(6), 1731-1740. https://doi.org/10.1111/1751-7915.13648
-Mukherjee, S., & Bassler, B. L. (2022). Bacterial quorum sensing in complex and dynamically
changing environments. Nature Reviews Microbiology, 20(1), 13-27. https://doi.org/10.1038/s41579-
-00604-4
-Wong, C. H., Hendrix, W. A., & Smith, J. (2021). Synthetic biology for antibiotic discovery: Expanding
the chemical space through novel biosynthetic pathways. Nature Chemical Biology, 17(3), 256-265.
https://doi.org/10.1038/s41589-021-00708-4
-Thakur, C. S., Cao, Y., & Zhang, X. (2021). Genome mining and synthetic biology for antibiotic
discovery. Current Opinion in Microbiology, 62, 73-82. https://doi.org/10.1016/j.mib.2021.05.006
-Alberti, F., & Corre, C. (2019). Editing antibiotic biosynthetic gene clusters in streptomycetes via
CRISPR/Cas9. Frontiers in Microbiology, 10, 1693. https://doi.org/10.3389/fmicb.2019.01693
-Fahnøe, U., & Bukh, J. (2019). A novel CRISPR/Cas9 system for targeted genome editing in archaea.
Journal of Bacteriology, 201(11), e00028-19. https://doi.org/10.1128/JB.00028-19
-Li, Xiaowei., & Elledge, Stephen J. (2012). Harnessing CRISPR–Cas9 for bacterial genome editing.
Nature Reviews Microbiology, 10(12), 769-778. https://doi.org/10.1038/nrmicro2888
- Micklefield, Jason., Wilkinson, Barrie., & Caddick, Steven. (2021). CRISPR-Cas9 gene editing
enables rapid engineering of complex antibiotic assembly lines. Nature Communications, 12, 6812.
https://doi.org/10.1038/s41467-021-27042-6
- Peters, Jennifer M., Colavin, Alexandre., & Weissman, Jonathan S. (2019). Engineering modular,
high-capacity biosynthetic pathways for the production of novel antibiotics. Journal of Industrial
Microbiology and Biotechnology, 46(4), 693-707. https://doi.org/10.1007/s10295-019-02187-w13-Mukai, Kenji., Nakano, Hiroshi., & Kawamura, Shohei. (2020). A novel gene cluster responsible for
the biosynthesis of an antibiotic compound in Streptomyces. Journal of Bacteriology, 202(12), e00519-
https://doi.org/10.1128/JB.00519-19
-Luo, Xiaoyu., & Zhang, Lei. (2016). CRISPR-Cas9-mediated genome editing in Streptomyces for
novel antibiotic production. Journal of Microbiology and Biotechnology, 26(4), 783-792.
https://doi.org/10.4014/jmb.1601.01019.
-Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2015). RNA-guided editing of bacterial
genomes using CRISPR-Cas systems. Nature Biotechnology, 33(4), 543-548.
https://doi.org/10.1038/nbt.3123
- Li, Xiaowei., Tian, Zhihong., & Ji, Wei. (2021). Engineering bacteria for the biosynthesis of novel
antibiotics using CRISPR/Cas9. Synthetic and Systems Biotechnology, 6(2), 123-131.
https://doi.org/10.1016/j.synbio.2020.11.002
-Namai, Ryutaro., Kojima, Miho., & Ohara, Takehiko. (2020). Genetically engineered Lactobacillus
for anti-inflammatory and antibiotic applications. Microbial Biotechnology, 13(4), 1054-1062.
https://doi.org/10.1111/1751-7915.13612
-Thakur, Chhavi S., Cao, Yuan., & Zhang, Xiangyun. (2021). Genome mining and synthetic biology
for antibiotic discovery. Current Opinion in Microbiology, 62, 73-82.
https://doi.org/10.1016/j.mib.2021.05.006
-Strain-Damerell, Claire M., Nicholson, Jeremy., & Willis, Richard J. (2021). Engineering
nonribosomal peptide synthetase enzymes for novel antibiotic production. Journal of Industrial
Microbiology and Biotechnology, 48(3-4), 453-468. https://doi.org/10.1007/s10295-021-02316-8.